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IRRITABLE BOWEL SYNDROME (IBS)
SIGNIFICANTLY AFFECTS PATIENT QUALITY
OF LIFE (QOL) AND IS RESPONSIBLE FOR HIGH
COSTS IN FRANCE:THE ENCOLI STUDY
Brun-Strang C1, Lafuma A2, Dapoigny M3,Wainsten JP4
1Novartis-Pharma, Rueil-Malmaison, France; 2CEMKA-EVAL,
Bourg La Reine, France; 3Hotel Dieu, Clermont-Ferrand,
France; 4Université Paris XII, Paris, France
OBJECTIVE: To describe the manage care in patients
presenting IBS and to evaluate, according to the severity
of the disease, the impact of the pathology in terms 
of quality of life (QOL) and resources used (RU).
METHODS: This is a 3-month transversal study of IBS
patients with a retrospective collection of information
covering the previous year. Socio-demographic character-
istics, clinical proﬁle, digestive symptoms, and treat-
ment information were collected. Patients were classiﬁed
according to the Rome I, II, and Mannings criteria.
Patients completed questionnaires to describe their level
of pain and discomfort (SGA), their RU (hospitalisations,
consultations, medications, tests), and work loss over the
last year. A generic QoL questionnaire, the Short Form
36 (SF-36), and a disease-speciﬁc QoL questionnaire (IBS-
QOL) were administered as well as a validated anxiety
and depression scale (HAD). A descriptive comparison of
groups of patients responding to the different IBS classi-
ﬁcation criteria was performed. IBS-related costs during
the previous one-year period were estimated, following a
societal perspective. RESULTS: Of the 445 patients who
had completed all questionnaires, there were 76% of
females; the mean age of the population was 54 ± 15
years. IBS patients had a markedly lower QoL than the
French general population. Nearly 23% of the patients
diagnosed with IBS did not meet any of currently accepted
diagnosis criteria, wheras 38% met all of the diagnostic
classiﬁcation critera. About 10% of IBS patients were
hospitalized for their IBS during the past year. The total
annual direct cost per patient was €773. CONCLU-
SIONS: These results conﬁrm that IBS exacts large direct
medical costs in France and that IBS patients experience
a lower QoL than the general population. Total direct
costs per patient were €773, which is equivalent to
average treatment costs of a French DNID patient 
(diabetic complications excluded).
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HEALTH STATE UTILITIES AND WILLINGNESS
TO PAY IN GERD PATIENTS WITH HEARTBURN
Kartman B
AstraZeneca R&D Mölndal, Mölndal, Sweden
OBJECTIVES: To estimate health state utilities and will-
ingness to pay (WTP) for symptom relief in patients with
gastroesophageal reﬂux disease (GERD), and to examine
the impact of frequency and severity of heartburn on 
utilities and WTP. METHODS: Five hundred four
Swedish GERD patients with heartburn as the predomi-
nant symptom were recruited by physicians. Data on 
utilities, WTP, annual number of days with heartburn
(frequency) and severity of heartburn (mild, moderate,
severe) were collected. Utilities were assessed using the
EuroQol and rating scale (RS). Another RS was used to
assess the utility as patients thought it would be without
heartburn. Annual WTP was assessed for a 25% and
50% reduction in frequency, using a binary question (BQ-
WTP) and a bidding game (BG-WTP). Linear regression
analysis was used to examine the impact of symptoms on
utilities and WTP, and to predict quality adjusted 
life-years (QALYs) gained from reduced symptoms.
RESULTS: Average RS and EuroQol utilities were 0.72
and 0.69. Average RS utility as it would be without heart-
burn was 0.85. Frequency and severity had a signiﬁcant
and negative impact on utilities. RS (EuroQol) utilities by
severity were 0.78, 0.70, 0.62 (0.78, 0.67, 0.51). Average
annual BQ-WTP for the 25% (50%) reduction was 6200
(8200) Swedish kronor. Average annual BQ-WTP for the
25% (50%) reduction was 5100 (6300). Frequency and
severity had a signiﬁcant and positive impact on WTP.
Implied BQ-WTP (BG WTP) per symptom free day
gained was 119 (95). Implied BQ-WTP (BG-WTP) 
per QALY gained was 328000 (263000) based on the
EuroQol and 661000 (530000) based on the RS. CON-
CLUSIONS: The signiﬁcant impact of heartburn on util-
ities and WTP support the validity of the utility and WTP
estimates. The results indicate that GERD patients with
heartburn assign their health states substantial disutility
and are willing to pay considerable amounts for symptom
relief.
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CORRELATION BETWEEN DIFFERENT
PRODUCTIVITY VARIABLES OBTAINED FROM
THE WPAI-GERD QUESTIONNAIRE
Wahlqvist P, Carlsson J
AstraZeneca R&D Mölndal, Mölndal, Sweden
A validation analysis of the Work Productivity and Activ-
ity Impairment questionnaire (WPAI) for assessing lost
productivity due to symptoms of gastroesophageal reﬂux
disease (GERD) has previously been reported, based on
results from a cross-sectional study of a Swedish working
population (N = 136) visiting a general practitioner due
to GERD. The construct validity of the WPAI-GERD was
found to be high, and patients with symptoms of GERD
(heartburn) reported an average of 2.5 hours absence
from work (AW), 23% reduced productivity while at
work (PW) and 30% reduced productivity while doing
regular daily activities (PA) during the week preceding the
consultation. OBJECTIVES: To carry out a further vali-
dation analysis of the WPAI-GERD by investigating the
relationship between the different productivity variables
obtained (AW, PW, PA). METHODS: Pearson correlation
coefﬁcients (PCC) between each productivity variable
were calculated based on results from the original study
